Table 3.
Results of Sensitivity Analysis
| Outcomes | Deletion | Result | |
|---|---|---|---|
| 6MWD | Öncü E 2017 | χ2=44.06, P<0.0001;I2=91% | MD76.96; 95% CI [41.13, 112.79] |
| Knaut C 2020 | χ2=34.12, P<0.0001;I2=88% | MD86.50; 95% CI [45.38, 127.61] | |
| He M 2015 | χ2=43.98, P<0.0001;I2=91% | MD83.66; 95% CI [33.47, 133.86] | |
| Greulich T 2014 | χ2=41.63, P<0.0001;I2=90% | MD66.34; 95% CI [35.68, 97.01] | |
| Borges RC 2014 | χ2=28.05, P<0.0001;I2=86% | MD55.45; 95% CI [29.10, 81.80] | |
| Lu H 2020 | χ2=26.21, P<0.0001;I2=85% | MD55.44; 95% CI [28.91, 81.97] | |
| SGRQ | Borges RC 2014 | χ2=0.90, P=0.34;I2=0% | MD-13.13; 95% CI [−16.52, −9.74] |
| Greulich T 2014 | χ2=0, P=0.99;I2=0% | MD-8.35; 95% CI [−16.16, −0.53] | |
| Knaut C 2020 | χ2=0.73, P=0.39;I2=0% | MD-13.25; 95% CI [−16.69, −9.81] | |
| DoHS | Borges RC 2014 | χ2=3.55, P=0.74;I2=0% | MD0.32; 95% CI [−0.03, 0.68] |
| Greulich T 2014 | χ2=6.92, P=0.33;I2=13% | MD0.27; 95% CI [−0.08, 0.62] | |
| Osadnik CR 2014 | χ2=6.91, P=0.33;I2=13% | MD0.26; 95% CI [−0.09, 0.61] | |
| Lu H 2020 | χ2=4.86, P=0.56;I2=0% | MD-0.22; 95% CI [−0.97, 0.52] | |
| Lopez Lopez L 2018 | χ2=6.90, P=0.33; I2I2=13% | MD0.26; 95% CI [−0.09, 0.61] | |
| Torres-Sánchez I 2018 | χ2=6.80, P=0.34;I2=12% | MD0.25; 95% CI [−0.11, 0.61] | |
| Lopez Lopez L2020 | χ2=5.89, P=0.44;I2=0% | MD0.31; 95% CI [−0.05,0.68] | |
| Knaut C 2020 | χ2=5.00, P=0.54;I2=0% | MD0.29; 95% CI [−0.06, 0.64] | |
| QMS | Vermeeren MA 2004 | χ2=0.22, P=0.64;I2=0% | MD28; 95% CI [13.30,42.69] |
| Torres-Sánchez I 2018 | χ2=5.49, P=0.02;I2=82% | MD14.43; 95% CI [−16.80,45.67] | |
| Lopez Lopez L 2019 | χ2=6.92, P=0.009;I2=86% | MD11.81; 95% CI [−12.15,35.78] | |
| 5 STS | Greulich T 2014 | χ2=0.66, P=0.72;I2=0% | MD-2.45; 95% CI [−7.79, 2.89] |
| Lopez Lopez L 2018 | χ2=2.17, P=0.34;I2=8% | MD-3.36; 95% CI [−8.59, 1.86] | |
| Lopez Lopez L 2019 | χ2=1.33, P=0.52;I2=0% | MD-6.30; 95% CI [−13.01, 0.42] | |
| Lopez Lopez L 2020 | χ2=2.41, P=0.30;I2=17% | MD-4.20; 95% CI [−10.10,1.71] | |